Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Urodynamic Studies: Uroflowmetry

Urodynamic Studies: Uroflowmetry

Uroflowmetry is a non-invasive urodynamic test designed to measure various aspects of urination, including volume, flow rate, and the time to void. This test is crucial for diagnosing and assessing conditions such as bladder outlet obstruction, bladder dysfunction, incomplete bladder emptying, incontinence, and urinary tract blockages caused by benign prostatic hyperplasia (BPH) and urethral strictures.Pre-Test Instructions:Before a uroflowmetry test, patients are typically advised to drink...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Upper urinary tract urothelial cell carcinoma].

Der Urologe. Ausg. A·2020

Same author

Preservation of the mesureter to reduce urinary complications: analysis of data from the observational Leipzig School MMR study.

BJOG : an international journal of obstetrics and gynaecology·2020

Same author

[Erratum to: Diagnosis and treatment of interstitial cystitis (IC/PBS). S2k guideline of the German Society of Urology].

Der Urologe. Ausg. A·2019

Same author

[Diagnosis and treatment of interstitial cystitis (IC/PBS) : S2k guideline of the German Society of Urology].

Der Urologe. Ausg. A·2019

Same author

[Robots in urology-an analysis of current and future devices].

Der Urologe. Ausg. A·2018

Same author

Translocation of a gut pathobiont drives autoimmunity in mice and humans.

Science (New York, N.Y.)·2018

Search research articles

Related Experiment Video

Updated: May 25, 2026

Autonomous and Rechargeable Microneurostimulator Endoscopically Implantable into the Submucosa

Autonomous and Rechargeable Microneurostimulator Endoscopically Implantable into the Submucosa

Published on: September 27, 2018

[Sacral neuromodulation in urology - development and current status].

T Schwalenberg¹, J-U Stolzenburg, C Kriegel

¹Klinik und Poliklinik für Urologie, Universitätsklinikum Leipzig AöR, Germany. thilo.schwalenberg@uniklinikleipzig.de

Aktuelle Urologie

|January 25, 2012

Summary

This summary is machine-generated.

Sacral neuromodulation (SNM) offers a potent treatment for refractory lower urinary tract dysfunction and chronic pelvic pain by stimulating sacral nerves. This therapy conditions neural structures, influencing bladder and rectal function for improved outcomes.

More Related Videos

Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models

Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models

Published on: August 9, 2012

Related Experiment Videos

Last Updated: May 25, 2026

Autonomous and Rechargeable Microneurostimulator Endoscopically Implantable into the Submucosa

Autonomous and Rechargeable Microneurostimulator Endoscopically Implantable into the Submucosa

Published on: September 27, 2018

Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models

Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models

Published on: August 9, 2012

Area of Science:

Urology
Neurology
Pelvic Floor Dysfunction

Context:

Refractory lower urinary tract dysfunction and chronic pelvic pain present significant clinical challenges.
Current treatment options may be insufficient for complex cases, necessitating advanced therapeutic modalities.

Purpose:

To provide an overview of Sacral Neuromodulation (SNM) as a treatment for lower urinary tract dysfunction and chronic pelvic pain.
To explain the mechanism of SNM, its biphasic treatment approach, and factors influencing success rates.

Summary:

Sacral neuromodulation (SNM) involves electrical stimulation of sacral afferents (S2–S4) to modulate autonomic and somatic neural pathways.
The therapy influences bladder, rectal, and sphincter function, addressing conditions like overactivity, hypocontractility, and bladder neck obstruction.
SNM is administered in two phases: a peripheral nerve evaluation (PNE test) followed by permanent electrode implantation if successful.
Recent advancements, including tined lead electrodes, have minimized tissue damage and improved treatment success rates, which range from 50–80%.

Impact:

SNM has become an established and potent treatment option in urology, particularly for therapy-refractory patients.
Technical innovations and financial feasibility have broadened its application in managing complex pelvic dysfunctions.
Improved surgical techniques and electrode designs contribute to enhanced long-term success rates and patient outcomes.